Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 04, 2015 7:03 AM ET

Company Overview of U.S. Centers For Disease Control And Prevention (cdc)

Company Overview

,  

United States

Key Executives for U.S. Centers For Disease Control And Prevention (cdc)

Director
Age: 55
Chief Operating Officer
Director of Coordinating Center for Health Promotion
Principal Deputy Director
Associate Director of Science
Compensation as of Fiscal Year 2015.

U.S. Centers For Disease Control And Prevention (cdc) Key Developments

Accelerate Diagnostics Announces Research Collaboration with U.S. Centers for Disease Control and Prevention for Early Detection of Antibiotic-Resistant Biothreat Agents

Accelerate Diagnostics, Inc. announced that it has entered into a research collaboration with the Rapid Antimicrobial Susceptibility Testing Laboratory at the U.S. Centers for Disease Control and Prevention (CDC) to develop tests for the rapid analysis of antibiotic-resistant biothreat agents based on Accelerate's high-speed identification and antibiotic susceptibility testing platform. Bacterial, biothreat agents and diseases such as anthrax, tularemia and plague pose significant national security and public health risks. While infections with these pathogens are rare in the United States, they can be disseminated or transmitted from person-to-person and result in high mortality rates. They therefore require special public health preparedness and surveillance so that any potential biothreat activity or disease outbreaks can be rapidly identified and contained. Early detection, isolation and treatment with effective antibiotics are critical to cure patients and limit the spread of disease. Unfortunately, conventional testing methods available in hospital and public health labs can take several days to produce results. These methods are therefore unable to provide critical, time sensitive information to the healthcare community, denying caregivers the opportunity to manage infection and prevent outbreaks at the earliest stage. Accelerate Diagnostics is developing a fully integrated, easy-to-use platform that provides high-speed identification and antibiotic susceptibility testing of pathogens, working directly from patient samples. The platform enables laboratories to provide critical microbiology results in hours instead of days. As part of the collaboration with the CDC laboratory, Accelerate Diagnostics will use its expertise to develop assays for rapid identification of key bacterial biothreat agents, their virulence markers, and their antibiotic susceptibility and resistance profiles. The CDC will provide scientific expertise on the microbiology and molecular biology of biothreat agents, and will evaluate and optimize the performance of the platform, using its collection of biothreat agents. As part of the agreement, the CDC has purchased the Accelerate ID/AST platform for use in their laboratory.

Centers for Disease Control and Prevention Elects Ruth Katz to the Board of Directors

Ruth Katz, J.D., M.P.H., has been elected to the board of directors of the Centers for Disease Control and Prevention (CDC) Foundation. Katz is the director of The Aspen Institute's Health, Medicine and Society (HMS) Program, an educational and policy studies organization. The HMS Program draws on the expertise of a diverse group of leaders in health and health policy to inform the national conversation on health, medicine and biomedical research. Katz has a long and distinguished career in public health and previously served as a member and secretary of the CDC Foundation's board of directors from 2004-2009.

U.S. Centers For Disease Control And Prevention (cdc) Presents at Milken Institute Global Conference 2014, Apr-27-2014 through Apr-30-2014

U.S. Centers For Disease Control And Prevention (cdc) Presents at Milken Institute Global Conference 2014, Apr-27-2014 through Apr-30-2014. Venue: Lon Angeles, California, United States. Presentation Date & Speakers: Apr-28-2014, Thomas R. Frieden, Director. Apr-29-2014, Thomas R. Frieden, Director.

Similar Private Companies By Industry

Company Name Region
Midwest Press And Automation, Llc United States
Grand View Media Group, Inc. United States
Eagle Shirtmakers Inc. United States
National Association Independant Insurance Rers United States
Albee Lamont Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact U.S. Centers For Disease Control And Prevention (cdc), please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.